Dechra Pharmaceuticals Share Price (DPH)

2,007.50 -13.50 (-0.67%) delayed: 1:27PM BST
Bid price 2,007.00 Open price 2,022.00
Ask price 2,008.00 Prev close 2,021.00
High price 2,029.00 Spread 0.05%
Low price 2,004.00 Volume 51,219

Register now for FREE live Dechra Pharmaceuticals share prices, Dechra Pharmaceuticals stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Dechra Pharmaceuticals Level 2 Data, indepth research tools and investor commentary for Dechra Pharmaceuticals (DPH) and other London Stock Exchange equities.

Dechra Pharmaceuticals Share Price Chart

Advanced Charts >>

Register now for FREE Dechra Pharmaceuticals share price charts

Dechra Pharmaceuticals Share Price Information

Name Dechra Pharmaceuticals Epic DPH
Sector Pharmaceuticals & Biotechnology ISIN GB0009633180
Activites Dechra Pharmaceuticals plc is an international veterinary pharmaceutical business. Its expertise is in the development, manufacturing, distribution, sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. Index FTSE 250

Dechra Pharmaceuticals Key Numbers

Latest Share Price (p) 2,007.50 Net Gearing (%) 42.98
Market Capitalisation (£m) 1,883.20 Gross Gearing (%) 52.57
Shares in issue (m) 93.18 Debt Ratio 47.06
P/E Ratio 71.95 Debt-to-Equity Ratio 0.80
Total dividends per share (p) 21.44 Assets / Equity Ratio 2.11
Dividend Yield (%) 1.06 Price to book value 6.22
Dividend cover (x) 1.31 ROCE (%) 5.00
Earning per share (p) 28.09 EPS Growth (%) 100.64
52 week high / low 2,149.00 / 1,225.00 DPS Growth (%) 16.14

Dechra Pharmaceuticals Director Deals

Dec.Date Type Director Pos No. of Shares
19/09/2017 EXR Ian Page CEO 115,334
19/09/2017 EXR Tony Griffin ED 29,937
04/09/2017 BUY Richard Cotton D 8,481
22/06/2017 SELL Ian Page CEO 134,500
24/04/2017 TOUT Ian Page CEO 6,600

More Dechra Pharmaceuticals Director Deals >>

Dechra Pharmaceuticals Company News

14:55 19/09/2017

Director Deals - Dechra Pharmaceuticals PLC (DPH)

Tony Griffin, Executive Director, exercised 29,937 shares in the company on the 19th September 2017 at a price of 0.00p. The Director now holds 94,257 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com

14:55 19/09/2017

Director Deals - Dechra Pharmaceuticals PLC (DPH)

Ian Page, Chief Executive Officer, exercised 115,334 shares in the company on the 19th September 2017 at a price of 0.00p. The Director now holds 792,142 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com

11:30 19/09/2017

Director/PDMR Shareholding

RNS Number : 1712R Dechra Pharmaceuticals PLC 19 September 2017         19 September 2017   Dechra® Pharmaceuticals PLC (Dechra or the Company)   Notification and public disclosure of transactions by persons discharging managerial...

More Dechra Pharmaceuticals Company News >>

Register now for FREE Dechra Pharmaceuticals company news

Dechra Pharmaceuticals Share Price Discussions

more than 1 year ago

A really dreary share (DPH)

A really dreary share! Dechra Pharmaceuticals manufactures and distributes vetinary products and equiptment.Has a few own brands:- Equipalazone,Vetoryl and Felimazole -anyone used them? My stockbroker molested me so much over this company that I finally bought at 130p,(Feb 04); now at 182.5p and...

Register now for FREE Dechra Pharmaceuticals share price discussions